Skip to main content
Erschienen in: BMC Infectious Diseases 1/2012

Open Access 01.12.2012 | Research article

Epidemiological and clinical features of human rabies cases in Bali 2008-2010

verfasst von: Ni M Susilawathi, Agus E Darwinata, Ida BNP Dwija, Nyoman S Budayanti, Gusti AK Wirasandhi, Ketut Subrata, Ni K Susilarini, Raka AA Sudewi, Frank S Wignall, Gusti NK Mahardika

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2012

Abstract

Background

Previously thought to be rabies free, Bali experienced an outbreak of animal and human rabies cases in November 2008. We describe the epidemiological and clinical data of human rabies cases occurring in the first two years of the outbreak.

Methods

We analysed the patient records of all rabies cases from the Sanglah General Hospital in Denpasar, and district hospitals in Buleleng and Tabanan. A conventional reverse transcriptase polymerase chain reaction was developed to detect the rabies virus genome in saliva, corneal swabs, and ante- and post-mortem cerebrospinal fluid (CSF).

Results

There were 104 human rabies cases in Bali during November 2008-November 2010. Patients' mean age was 36.6 years (range 3-84 years; SD 20.7), most were male (56.7%), and originated from rural districts. Almost all (92%) cases had a history of dog bite. Only 5.8% had their wounds treated and received an anti-rabies vaccine (ARV) after the bite incident. No patients received rabies immunoglobulin (RIG). The estimated time from dog bite to the onset of signs and symptoms was 110.4 days (range 12-720 days; SD 118.2). The mean length of medical care until death was 21.8 hours (range 1-220 hours; SD 32.6). Less than 50% of patients had prodromal symptoms. The most frequent prodromal symptom was pain or paraesthesia at the bite site (37.6%). The two most common central nervous system infection signs were agitation (89.2%) and confusion (83.3%). Signs of autonomic nervous system dysfunction included hydrophobia (93.1%), hypersalivation (88.2%), and dyspnea (74.4%). On admission, 22 of 102 patients (21.6%) showed paralytic manifestations, while the rest (78.4%) showed furious rabies manifestations. The case-fatality rate was 100%. The rabies virus genome was detected in 50 of 101 patients (49.5%) with the highest detection rate from post-mortem CSF samples.

Conclusions

Rabies is a major public health problem in Bali. Human fatalities occur because of a lack of knowledge regarding rabies risk, the poor management of dog bites, and the limited availability of RIG. Increasing public awareness of dog bite management, increasing the availability of ARV and RIG, and implementing an island-wide dog vaccination campaign will help prevent human rabies cases.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2334-12-81) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

Ni M Susilawathi, Gusti A K Wirasandhi, and Ketut Subrata contributed to data collection at the provincial and district hospitals. Agus E Darwinata, Ida B N P Dwija, and Nyoman S Budayanti contributed to rabies genome detection, data entry, and data analysis. Ni K Susilarini contributed to obtaining ethical clearance. Frank S Wignall contributed to project planning and supervision. Raka AA Sudewi and Gusti NK Mahardika planned and co-supervised the study and drafted the manuscript.

Background

Rabies is a fatal neuropathogenic disease caused by the rabies virus, which is an enveloped RNA virus of the Lyssavirus genus, Rhabdoviridae family [1]. Rabies has a global distribution, with the exception of Antarctica, and infects domestic and wild animals. The rabies virus is transmitted to humans through the saliva of infected animals. The main route of infection is the bite of rabid dogs. Rabies is nearly always fatal when left untreated [2].
Rabies has been reported in Indonesia since the nineteenth century. The virus has been endemic in various islands surrounding Bali, including Sumatra, Java, Kalimantan, Sulawesi, and Flores since 2000 (review in [3]). Bali was considered rabies free until late November 2008, but an island-wide rabies outbreak has since occurred. Bali is a densely populated island with 3.9 million inhabitants in 5600 km2 and with a dog-density of over 100 per km2, one of the highest in the world [4, 5]. The number of dog bite incidents in Bali is high, with 21,806 reported in 2009 and 48,298 as of November 2010. The daily average of nearly one hundred dog bite incidents establishes the seriousness of the problem. Dog bites were common in Bali before 2008, but the number of victims seeking medical treatment was not high. Surveillance and recording of bite incidents was not conducted prior to 2008, because the risk of rabies was considered negligible. Rabies has been confirmed in both dogs and humans since November 2008 and 104 human cases were clinically diagnosed between November 2008 and November 2010. All human cases were fatal. We will now describe the epidemiological and clinical features of these human rabies cases occurring in Bali.

Methods

Data collection

Bali's health system includes Community Health Centres at the sub-district level, district hospitals, private hospitals, and one provincial referral hospital, namely the Sanglah General Hospital in Denpasar. After the outbreak of rabies began, some community health centres in the Badung and Tabanan districts were appointed as rabies treatment centres. Medical records were kept for all dog bite and human rabies cases seeking medical attention. The patient records from Sanglah and the district hospitals in Buleleng and Tabanan were the primary data sources of this study. Patients from other districts were referred to Sanglah Hospital for treatment. Data included the origin, age, and sex of the patient, estimated bite date, bite site, length of hospital care, presence of various prodromal clinical signs, and signs of central and autonomic nervous system dysfunction. We analysed all available data collected since the index human rabies case in November 2008.

Ethical approval

Ethical clearance for this study was granted by the Research Ethics Committee of the Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia, reference number 723/Skrt/XI/2010 dated November 12th, 2010. Written informed consent was obtained from the patients' families before the samples and patient data were collected.

Sample collection

Cerebrospinal fluid (CSF), saliva, and corneal swabs were obtained from the rabies patients. Ante-mortem CSF was collected by lumbar puncture. Post-mortem CSF was collected by sub-occipital puncture. Specimens were collected without preservative and stored directly at -80°C.

Rabies genome detection and sequencing

Genomic RNA was isolated using a Pure-Link Viral RNA Isolation Kit (Invitrogen). Reverse transcriptase polymerase chain reaction (RT-PCR) was performed with a SuperScriptTM III One-Step RT-PCR System with Platinum® Taq DNA Polymerase (Invitrogen) following the manufacturer's protocol. Primer set for the rabies RT-PCR was designed based on the rabies-virus sequence data from dogs in Indonesia that was available in GenBank using the web-based primer design tool Primer 3 http://​biotools.​umassmed.​edu. The primer sequences used were 5'- TCAGGTGGTCTCYTTGAAGCC-3' (NF36) and 5'- ACGAACGGAAGTGGATGAAA-3' (NR836). A rabies-positive dog brain sample was used as positive control. This sample is available at the Animal Biomedical and Molecular Biology Laboratory of Udayana University. The sensitivity of the RT-PCR was 100% when compared with standard fluorescence antibody testing for rabies detection in dog brains (unpublished data). The RT-PCR conditions included incubation at 50°C for 60 minutes followed by incubation at 95°C for 7 minutes. The PCR cycle was 30 seconds at 94°C, 30 seconds at 55°C, and 60 seconds at 72°C. The cycle was repeated 35 times and followed by incubation at 72°C for five minutes. The RT-PCR was carried out using an MJMini Personal Thermal Cycler (Bio-Rad, Hercules, CA). The RT-PCR product was electrophoresed in 1% agarose gel stained with ethidium bromide and visualized in a UV transilluminator. For sequencing, the RT-PCR products were purified using a QIAquick PCR Purification Kit (Qiagen). Sequencing reactions were performed with a Big Dye Terminator v3.1 Cycle Sequencing Kit and run in an Applied Biosystem 3130/3130x Genetic Analyzer, which is an automated DNA sequencer. The sequencing work was performed at the Eijkman Institute for Molecular Biology, Jakarta, Indonesia. Trace identification was performed using Sequence Scanner Ver1.0 http://​www.​appliedbiosystem​s.​com. The sequence was aligned using Mega4 software [6] and compared with the GenBank database using the basic local alignment search tool http://​www.​ncbi.​nlm.​nih.​gov/​blast/​Blast.​cgi.

Results

Data of 104 patients, all of whom died of rabies in Bali from November 2008 until November 30, 2010, were used for analysis. The average patient age was 36.6 years (range 3-84 years, SD = 20.7). The victims were mostly male (56.7%). Figure 1 shows the number of human rabies cases by month for the initial two-year period of the outbreak. The increase in numbers of clinically diagnosed cases in 12 months after the initial case report can be seen. Cases were reported in eight districts (Figure 2) with most coming from rural districts, including Karangasem (28.8%), Buleleng (19.2%) and Tabanan (17.3%). The proportion from the Badung District, where the index case occurred was 13.5% (Figure 2).
Of the 104 cases, 96 had a history of dog bite. Dog-bite history information was missing for eight patients who were unconscious at presentation and whose family members were not aware of any incidents. Bites were most common in the lower extremities (59.3%), followed by the upper extremities (37.2%) and the head and neck (3.5%). Single bite cases were more frequent (72.9%) than multiple bite cases (27.1%).
Most patients (80.8%) had not undergone wound treatment of any kind, while 10.6% of them washed the wound themselves and 5.8% of them went to hospital on the day of the incident because of its severity, had their wounds cleaned and were given the anti-rabies vaccine (ARV). None of the cases received rabies immunoglobulin (RIG). Not all of the vaccinated patients completed their ARV regimens before developing the clinical symptoms of rabies.
The incubation period for the development of clinical rabies varied from as short as 12 days to as long as two years. In 98% of the cases, the incubation period was under one year. The incubation period was only 12-21 days when the bite site was on the head and neck, while it was 25 days to two years when on the extremities.
The list of clinical signs observed is presented in Table 1. Early recorded symptoms included pain or paraesthesia at the bite site (36.5%), nausea or vomiting (29.8%), fever (21.8%), myalgia (17.3%), headache (16.3%), and insomnia (6.7%).
Table 1
List of the clinical signs of the human rabies cases in Bali, November 2008-2010
Clinical Sign*
Number of Patient show the sign/total number of valid data
Frequency
Prodromal symptoms
Pain/Paraesthesia at bite site
38/101
37.6%
Nausea and Vomiting
31/101
30.7%
Fever
22/101
21.8%
Myalgia
18/101
17.8%
Insomnia
7/101
6.9%
Headache
17/101
16.8%
Clinical sign of central nervous system infection
Agitation
91/102
89.2%
Confusion
85/102
83.3%
Urine incontinence
28/102
27.5%
Flaccid Paralysis
22/102
21.6%
Seizure
16/102
15.7%
Hyperexcitability
14/102
13.7%
Abdominal discomfort
11/102
10.8%
Fasciculation and Tremor
4/102
3.9%
Cranial nerve involvement
(Ophthalmoplegia, facial weakness and impaired swallowing)
3/102
2.9%
Autonomic dysfunction
Hydrophobia
95/102
93.1%
Hypersalivation
90/102
88.2%
Aerophobia
76/102
74.5%
Dyspnea
76/102
74.5%
Photophobia
31/102
30.4%
Hyperhydrosis
27/102
26.5%
Piloerection
5/102
4.9%
*Clinical signs are ranked from the most to least common
The acute neurological signs were either furious (79.8%) or paralytic (20.2%). In the furious cases, 89.2% of patients showed intermittent agitation and confusion. Signs of autonomic dysfunction [7] were hydrophobia (93.1%), hypersalivation (88.2%), aerophobia (73.1%), dyspnea (74.5%), photophobia (29.8%) and piloerection (4.8%). Other signs included fever (18.2%), muscle fasciculation (3.8%), and convulsions (15.4%). Cranial nerve involvement and ophthalmoplegia, facial weakness and dysphagia were reported in 2.9% of patients. In the paralytic rabies cases, signs of flaccid paralysis were recorded in 21% of patients, urinary incontinence in 27.5%, and abdominal discomfort in 10.8%. The acute signs ended with abrupt death or progression into coma before death.
Laboratory rabies diagnosis was carried with the RT-PCR technique on collected saliva, corneal swab, and ante- and post-mortem cerebrospinal fluid (CSF) specimens. A photograph of 1% agarose gel showing the positive detection of rabies nucleoprotein from CSF samples following one-step RT-PCR is presented in Figure 3. Rabies RNA was detected in 50 of 101 patients (49.5%). The highest detection rate was from post-mortem CSF specimens (detected in 8 of 15 patients). The RT-PCR detection rate from various specimens is presented in Table 2. The sequence of the rabies virus nucleoprotein from one patient has been deposited in GenBank with Accession Number JQ768453. This sequence showed a specific rabies genome fragment that was closely related to a rabies virus sequence from Indonesia that is available in GenBank.
Table 2
Summary of RT-PCR detection results from various specimens of human rabies cases in Bali 2008-2010
Specimen
Number of samples
Positives
Frequency of positive detection (%)
Saliva
101
28
27.7
Corneal Swab
86
4
4.6
Ante-mortem CSF
48
10
20.8
Post-mortem CSF
15
8
53.3

Discussion

At the onset of the rabies outbreak, the human rabies management systems in Bali were unprepared. Doctors were not experienced in rabies diagnosis. Intensive training on rabies diagnosis and management was provided to health care workers following rabies confirmation in the index case. A case definition was developed under the guidance of the Ministry of Health [8], and it included clinical signs of rabies and a dog bite history. Initial case management often depended on the patient's complaints on arrival at the hospital and some misidentified cases ended up in cardiology for chest pain; others in internal medicine wards because of dyspepsia, typhoid fever, urinary colic, or paralytic ileus or pulmonology section for breathing difficulties, or abdominal surgery because of suspected appendicitis. Only after classical rabies symptoms appeared were patients transferred to Neurology departments for management. Given the largely passive rabies surveillance in Bali, it is possible that some cases will not have been recorded.
Standard diagnostic procedures were also not yet available in Bali at the onset of the rabies epidemic. Initial detection by RT-PCR was performed at Udayana University to confirm the outbreak. The initial goal was to find a positive sample that could be confirmed by sequencing, because RT-PCR sensitivity had not yet been evaluated. The standard fluorescent antibody test (FAT) [1] was not performed because the required equipment was not available. Samples collected included CSF, saliva, and corneal swabs along with ante- and post-mortem CSF. Cervical skin samples, although reported as a reliable source for diagnosis of human rabies [9], were not collected.
A diagnosis of rabies can also be established clinically and is the official standard for human cases [8]. Although the results of a RT-PCR test may be negative, rabies cases can still be clinically confirmed. A clinical diagnosis is not difficult if there is a history of a rabid or suspected dog bite. In other instances, rabies can be considered when there is an acute neurological disease that progresses to coma and death [1].
The Province of Bali, Indonesia, was not known to be a rabies endemic area prior to November 2008. The index human rabies case was reported in the Badung District (Figure 2) and it was followed by rabies detection in many dogs. The local government control policy was initially a combination of dog vaccination and dog elimination. However, the movement of dogs during the incubation period to rabies-free areas probably contributed to the spread of the virus (Figure 2). By early 2010, the disease had spread throughout the entire island and the initial extensive dog culling was not successful in stopping the outbreak. Data also indicated that most cases occurred in the Karangasem and Buleleng districts in densely populated but rural areas. Large numbers of semi-feral, unvaccinated dogs along with a lack of rabies knowledge, and poor socioeconomic conditions common to other outbreaks [10, 11] also contributed to uncontrolled rabies spread among dogs and the poor management of human infections.
This report illustrates that most patients did not receive proper first aid, rabies vaccination, or passive immunization post-exposure. Of 104 patients, only 5.8% sought medical help and received post-exposure vaccination. RIG was not available to them. Among those given initial treatment, the vaccination regimens were not completed because of a short incubation period and the onset of symptoms within two weeks of bites on the head and neck region.
All epidemiological features of the human rabies cases in Bali resemble those reported elsewhere. Rabies victims in Bali were mostly male, similar to China [11]. The bite locations were mostly on patients' legs and arms. Bites on the head and neck were less frequent. In China [11] and Tanzania [12], bites on the head and neck contributed significantly to the number of human rabies cases. The age distribution of rabies patients in Bali was similar to those in reported in China and Taiwan.
Dogs were the source of human rabies infections in Bali. Infections in other animals that might theoretically transmit the virus to humans, such as cats and bats, have not yet been confirmed. Dogs are known as the most common source of rabies transmission to humans throughout the world, especially in Asia, Latin America, and Africa [1].
In this study, the incubation period of human rabies ranged from 60-90 days post bite in most cases. A shorter incubation period of 12-21 days was recorded in patients with bites around the head and neck. This is a typical picture of rabies in humans. It is well understood that the rabies incubation period is one of the most variable among all infections. The average incubation period is around 1-3 months but may range from less than 7 days to 6 years [1, 13]. The incubation period depends on several factors such as bite site, virus quantity in the saliva, type and depth of the bite wound, and viral virulence [14]. Longer incubation periods might lead to problems in making a diagnosis when the history of a bite might be forgotten [15].
Rabies infection in humans is triphasic, i.e., prodromal, acute neurologic, and coma proceeding to death [16]. The prodromal signs are mostly non-specific, including fever, headache, myalgia, nausea, vomiting, and abnormal sensation around bite sites, such as itching, burning, numbness, or paraesthesia [17]. These non-specific complaints may lead to a misdiagnosis of rabies at this early stage [15]. In nearly 50% of paralytic rabies cases and 30% of furious rabies cases, local manifestation in the form of itching, pain or paresthesia at the bite site may be the earliest symptom [13].
The vagueness of prodromal signs was evident in the human rabies cases in Bali. The three most common prodromal signs observed in this study were paraesthesia at the bite site, nausea, vomiting, and fever. In Bali, about 30% of the rabies patients complained of these signs on admission to the medical facilities.
Most patients (98%) were in the acute neurological phase on arrival at the hospitals. The most dominant signs were acute neurological and autonomic dysfunction. Typically, human rabies patients show anxiety, agitation, dysphagia, hypersalivation, paralysis, and episodes of delirium. A case is classified as being furious rabies if the hyperactivity signs are dominant, or as paralytic or dumb rabies if the patient presents with varying degrees of paralysis and lethargy (review in [1]). However, this classification does not seem to be clear-cut. Clinically, furious rabies should be easier to establish than paralytic rabies. The paralytic type is caused by virus infection in the spinal cord [18]. In some cases of human rabies in Bali, the patients showed paralytic symptoms on admission and then developed furious symptoms in the later stages.
The standard methods for rabies diagnosis in humans are virus isolation, antigen detection, and viral genome detection [1921]. Confirmation should be made after virus detection using FAT and immunohistochemistry from CNS specimens [22, 20, 23]. The infrastructure to perform such testing was not available in Bali. RT-PCR has been recommended to detect virus specific RNA [2024]. The specimens selected for this technique include brain, saliva, and other affected tissues. Accordingly, a RT-PCR system was developed to detect and confirm human rabies infections in Bali. Primer sets were selected based on an existing Indonesian rabies-genome database available in GenBank, and commercially purchased. The system was proven to detect the rabies genome in patients. RT-PCR has been reported to have a high specificity (up to 100%) and a moderate level of sensitivity [13]. This is similar to our detection level of about 50% of the clinical rabies patients. Rabies infection cannot be ruled out of the RT-PCR negative specimens. Our observations indicate that among the samples taken, the best sample for RT-PCR detection is CSF. Other publications found a higher PCR positivity rate early in the disease progression when neutralizing antibodies are not present or are at a low titre [13]. While a positive PCR result is indicative of rabies, a negative result does not exclude it.
Rabies prevention is all about awareness. The public must be informed about all relevant aspects of rabies and rabies control. Community initiatives should ensure sustainable control of canine rabies and proper management of dog bites to prevent rabies infections in humans. Such initiatives rely on community knowledge and a willingness to cooperate. Information on the cause of rabies, its seriousness, how it is transmitted, its signs in animals and humans, and on the medical management of dog bites need to be widely disseminated. The adequacy of government policies on rabies control should be reviewed and international policy standards should be met. The most efficient measure for human protection is actually the vaccination of dogs. As proven worldwide, the elimination of canine rabies and the prevention of human rabies mortality is feasible through mass vaccination of domestic dogs [12, 2527]. Public awareness must be continuously maintained, not only in rabies infected areas but also on neighbouring islands that have never experienced the disease [28, 29].
Unsuccessful control of canine ra cbies and inadequate post-exposure prophylaxis (PEP) in humans are the main factors leading to the high incidence of human rabies infection in Bali. Publicity and education about the risk and prevention of rabies, as well as high rates of dog vaccination, properly trained medical personnel, and adequate vaccine and RIG supplies are necessary and important for the elimination of human rabies cases and the care of those potentially exposed.

Conclusions

Rabies has emerged as a major public health problem in Bali. Human rabies fatalities have occurred because of a lack of knowledge regarding rabies risk and poor management of dog bite incidents, including poor wound cleaning and failure to seek PEP. The limited availability of RIG for the treatment of high-risk rabid dog bites also contributed to the high fatality rate. Public awareness regarding dog and wound management, as well as ensuring the availability of ARV and RIG are the keys to preventing human rabies cases. An island-wide vaccination campaign should be undertaken to eliminate canine rabies.

Acknowledgements

The Li Ka Shing Foundation-University of Oxford Global Health Programme supported this study. The authors thank the patient's families for participating in the study and the caregivers in the health centres and hospitals for their cooperation.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

Ni M Susilawathi, Gusti A K Wirasandhi, and Ketut Subrata contributed to data collection at the provincial and district hospitals. Agus E Darwinata, Ida B N P Dwija, and Nyoman S Budayanti contributed to rabies genome detection, data entry, and data analysis. Ni K Susilarini contributed to obtaining ethical clearance. Frank S Wignall contributed to project planning and supervision. Raka AA Sudewi and Gusti NK Mahardika planned and co-supervised the study and drafted the manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
1.
Zurück zum Zitat De Mattos CA, De Mattos CC, Rupprecht CE: Rhabdoviruses. Fields Virology. Edited by: Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE. 2001, Philadelphia: Lippincott Williams & Wilkins, 1: 1245-1277. 4 De Mattos CA, De Mattos CC, Rupprecht CE: Rhabdoviruses. Fields Virology. Edited by: Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE. 2001, Philadelphia: Lippincott Williams & Wilkins, 1: 1245-1277. 4
2.
Zurück zum Zitat Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, et al: Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008, 57 (RR-3): 1-28.PubMed Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, et al: Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008, 57 (RR-3): 1-28.PubMed
3.
Zurück zum Zitat Susetya H, Sugiyama M, Inagaki A, Ito N, Mudiarto G, Minamoto N: Molecular epidemiology of rabies in Indonesia. Virus Res. 2008, 135 (1): 144-149. 10.1016/j.virusres.2008.03.001.CrossRefPubMed Susetya H, Sugiyama M, Inagaki A, Ito N, Mudiarto G, Minamoto N: Molecular epidemiology of rabies in Indonesia. Virus Res. 2008, 135 (1): 144-149. 10.1016/j.virusres.2008.03.001.CrossRefPubMed
4.
Zurück zum Zitat Childs JE, Robinson LE, Sadek R, Madden A, Miranda ME, Miranda NL: Density estimates of rural dog populations and an assessment of marking methods during a rabies vaccination campaign in the Philippines. Prev Vet Med. 1998, 33 (1-4): 207-218. 10.1016/S0167-5877(97)00039-1.CrossRefPubMed Childs JE, Robinson LE, Sadek R, Madden A, Miranda ME, Miranda NL: Density estimates of rural dog populations and an assessment of marking methods during a rabies vaccination campaign in the Philippines. Prev Vet Med. 1998, 33 (1-4): 207-218. 10.1016/S0167-5877(97)00039-1.CrossRefPubMed
5.
Zurück zum Zitat Kitala PM, McDermott JJ, Kyule MN, Cathuma JM: Features of dog ecology relevant to rabies spread in Machakos District, Kenya. Onderstepoort J Vet Res. 1993, 60 (4): 445-449.PubMed Kitala PM, McDermott JJ, Kyule MN, Cathuma JM: Features of dog ecology relevant to rabies spread in Machakos District, Kenya. Onderstepoort J Vet Res. 1993, 60 (4): 445-449.PubMed
6.
Zurück zum Zitat Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007, 24 (8): 1596-1599. 10.1093/molbev/msm092.CrossRefPubMed Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007, 24 (8): 1596-1599. 10.1093/molbev/msm092.CrossRefPubMed
7.
Zurück zum Zitat Jackson AC: Case 21-1998: rabies. N Engl J Med. 1999, 340 (1): 65-10.1056/NEJM199901073400119.CrossRefPubMed Jackson AC: Case 21-1998: rabies. N Engl J Med. 1999, 340 (1): 65-10.1056/NEJM199901073400119.CrossRefPubMed
8.
Zurück zum Zitat MoH: Guidance for planning and management of suspected rabid animal biting accidence. Directorate General of Disease Control and Environment Health, Indonesian ministry of health (MoH). 2011, Jakarta: Indonesian Ministry of Health, 1-32. MoH: Guidance for planning and management of suspected rabid animal biting accidence. Directorate General of Disease Control and Environment Health, Indonesian ministry of health (MoH). 2011, Jakarta: Indonesian Ministry of Health, 1-32.
9.
Zurück zum Zitat Dacheux L, Reynes JM, Buchy P, Sivuth O, Diop BM, Rousset D, Rathat C, Jolly N, Dufourcq JB, Nareth C, et al: A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis. 2008, 47 (11): 1410-1417. 10.1086/592969.CrossRefPubMed Dacheux L, Reynes JM, Buchy P, Sivuth O, Diop BM, Rousset D, Rathat C, Jolly N, Dufourcq JB, Nareth C, et al: A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis. 2008, 47 (11): 1410-1417. 10.1086/592969.CrossRefPubMed
10.
Zurück zum Zitat Knobel DL, Cleaveland S, Coleman PG, Fevre EM, Meltzer MI, Miranda ME, Shaw A, Zinsstag J, Meslin FX: Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ. 2005, 83 (5): 360-368.PubMedPubMedCentral Knobel DL, Cleaveland S, Coleman PG, Fevre EM, Meltzer MI, Miranda ME, Shaw A, Zinsstag J, Meslin FX: Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ. 2005, 83 (5): 360-368.PubMedPubMedCentral
11.
Zurück zum Zitat Song M, Tang Q, Wang DM, Mo ZJ, Guo SH, Li H, Tao XY, Rupprecht CE, Feng ZJ, Liang GD: Epidemiological investigations of human rabies in China. BMC Infect Dis. 2009, 9: 210-10.1186/1471-2334-9-210.CrossRefPubMedPubMedCentral Song M, Tang Q, Wang DM, Mo ZJ, Guo SH, Li H, Tao XY, Rupprecht CE, Feng ZJ, Liang GD: Epidemiological investigations of human rabies in China. BMC Infect Dis. 2009, 9: 210-10.1186/1471-2334-9-210.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Hampson K, Dushoff J, Cleaveland S, Haydon DT, Kaare M, Packer C, Dobson A: Transmission dynamics and prospects for the elimination of canine rabies. PLoS Biol. 2009, 7 (3): e53-10.1371/journal.pbio.1000053.CrossRefPubMed Hampson K, Dushoff J, Cleaveland S, Haydon DT, Kaare M, Packer C, Dobson A: Transmission dynamics and prospects for the elimination of canine rabies. PLoS Biol. 2009, 7 (3): e53-10.1371/journal.pbio.1000053.CrossRefPubMed
13.
Zurück zum Zitat Madhusudana SN, Sukumaran SM: Antemortem diagnosis and prevention of human rabies. Ann Indian Acad Neurol. 2008, 11 (1): 3-12. 10.4103/0972-2327.40219.CrossRefPubMedPubMedCentral Madhusudana SN, Sukumaran SM: Antemortem diagnosis and prevention of human rabies. Ann Indian Acad Neurol. 2008, 11 (1): 3-12. 10.4103/0972-2327.40219.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Jackson AC, Scott CA, Owen J, Weli SC, Rossiter JP: Therapy with minocycline aggravates experimental rabies in mice. J Virol. 2007, 81 (12): 6248-6253. 10.1128/JVI.00323-07.CrossRefPubMedPubMedCentral Jackson AC, Scott CA, Owen J, Weli SC, Rossiter JP: Therapy with minocycline aggravates experimental rabies in mice. J Virol. 2007, 81 (12): 6248-6253. 10.1128/JVI.00323-07.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Kienzle TE: Rabies. 2006, New York, NY: Chelsea House Kienzle TE: Rabies. 2006, New York, NY: Chelsea House
16.
Zurück zum Zitat Hemachudha T: Human rabies: clinical aspects, pathogenesis, and potential therapy. Curr Top Microbiol Immunol. 1994, 187: 121-143. 10.1007/978-3-642-78490-3_7.PubMed Hemachudha T: Human rabies: clinical aspects, pathogenesis, and potential therapy. Curr Top Microbiol Immunol. 1994, 187: 121-143. 10.1007/978-3-642-78490-3_7.PubMed
17.
Zurück zum Zitat Dupont JR, Earle KM: Human rabies encephalitis. A study of forty-nine fatal cases with a review of the literature. Neurology. 1965, 15 (11): 1023-1034.CrossRefPubMed Dupont JR, Earle KM: Human rabies encephalitis. A study of forty-nine fatal cases with a review of the literature. Neurology. 1965, 15 (11): 1023-1034.CrossRefPubMed
18.
Zurück zum Zitat Burton EC, Burns DK, Opatowsky MJ, El-Feky WH, Fischbach B, Melton L, Sanchez E, Randall H, Watkins DL, Chang J, et al: Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients. Arch Neurol. 2005, 62 (6): 873-882. 10.1001/archneur.62.6.873.CrossRefPubMed Burton EC, Burns DK, Opatowsky MJ, El-Feky WH, Fischbach B, Melton L, Sanchez E, Randall H, Watkins DL, Chang J, et al: Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients. Arch Neurol. 2005, 62 (6): 873-882. 10.1001/archneur.62.6.873.CrossRefPubMed
19.
Zurück zum Zitat Hanlon CA, Smith JS, Anderson GR: Recommendations of a national working group on prevention and control of rabies in the United States. Article II: Laboratory diagnosis of rabies. The National Working Group on Rabies Prevention and Control. J Am Vet Med Assoc. 1999, 215 (10): 1444-1446.PubMed Hanlon CA, Smith JS, Anderson GR: Recommendations of a national working group on prevention and control of rabies in the United States. Article II: Laboratory diagnosis of rabies. The National Working Group on Rabies Prevention and Control. J Am Vet Med Assoc. 1999, 215 (10): 1444-1446.PubMed
20.
Zurück zum Zitat Smith J, McElhinney LM, Heaton PR, Black EM, Lowings JP: Assessment of template quality by the incorporation of an internal control into a RT-PCR for the detection of rabies and rabies-related viruses. J Virol Methods. 2000, 84 (2): 107-115. 10.1016/S0166-0934(99)00124-X.CrossRefPubMed Smith J, McElhinney LM, Heaton PR, Black EM, Lowings JP: Assessment of template quality by the incorporation of an internal control into a RT-PCR for the detection of rabies and rabies-related viruses. J Virol Methods. 2000, 84 (2): 107-115. 10.1016/S0166-0934(99)00124-X.CrossRefPubMed
21.
Zurück zum Zitat Warner C, Fekadu M, Whitfield S, Shaddock J: Use of anti-glycoprotein monoclonal antibodies to characterize rabies virus in formalin-fixed tissues. J Virol Methods. 1999, 77 (1): 69-74. 10.1016/S0166-0934(98)00136-0.CrossRefPubMed Warner C, Fekadu M, Whitfield S, Shaddock J: Use of anti-glycoprotein monoclonal antibodies to characterize rabies virus in formalin-fixed tissues. J Virol Methods. 1999, 77 (1): 69-74. 10.1016/S0166-0934(98)00136-0.CrossRefPubMed
22.
Zurück zum Zitat Tepsumethanon V, Lumlertdacha B, Mitmoonpitak C, Fagen R, Wilde H: Fluorescent antibody test for rabies: prospective study of 8,987 brains. Clin Infect Dis. 1997, 25 (6): 1459-1461. 10.1086/516151.CrossRefPubMed Tepsumethanon V, Lumlertdacha B, Mitmoonpitak C, Fagen R, Wilde H: Fluorescent antibody test for rabies: prospective study of 8,987 brains. Clin Infect Dis. 1997, 25 (6): 1459-1461. 10.1086/516151.CrossRefPubMed
23.
Zurück zum Zitat Hamir AN, Moser G, Fu ZF, Dietzschold B, Rupprecht CE: Immunohistochemical test for rabies: identification of a diagnostically superior monoclonal antibody. Vet Rec. 1995, 136 (12): 295-296. 10.1136/vr.136.12.295.CrossRefPubMed Hamir AN, Moser G, Fu ZF, Dietzschold B, Rupprecht CE: Immunohistochemical test for rabies: identification of a diagnostically superior monoclonal antibody. Vet Rec. 1995, 136 (12): 295-296. 10.1136/vr.136.12.295.CrossRefPubMed
24.
Zurück zum Zitat Noah DL, Drenzek CL, Smith JS, Krebs JW, Orciari L, Shaddock J, Sanderlin D, Whitfield S, Fekadu M, Olson JG, et al: Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med. 1998, 128 (11): 922-930.CrossRefPubMed Noah DL, Drenzek CL, Smith JS, Krebs JW, Orciari L, Shaddock J, Sanderlin D, Whitfield S, Fekadu M, Olson JG, et al: Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med. 1998, 128 (11): 922-930.CrossRefPubMed
25.
Zurück zum Zitat Kaare M, Lembo T, Hampson K, Ernest E, Estes A, Mentzel C, Cleaveland S: Rabies control in rural Africa: evaluating strategies for effective domestic dog vaccination. Vaccine. 2009, 27 (1): 152-160. 10.1016/j.vaccine.2008.09.054.CrossRefPubMed Kaare M, Lembo T, Hampson K, Ernest E, Estes A, Mentzel C, Cleaveland S: Rabies control in rural Africa: evaluating strategies for effective domestic dog vaccination. Vaccine. 2009, 27 (1): 152-160. 10.1016/j.vaccine.2008.09.054.CrossRefPubMed
26.
Zurück zum Zitat Lembo T, Hampson K, Kaare MT, Ernest E, Knobel D, Kazwala RR, Haydon DT, Cleaveland S: The feasibility of canine rabies elimination in Africa: dispelling doubts with data. PLoS Negl Trop Dis. 2010, 4 (2): e626-10.1371/journal.pntd.0000626.CrossRefPubMedPubMedCentral Lembo T, Hampson K, Kaare MT, Ernest E, Knobel D, Kazwala RR, Haydon DT, Cleaveland S: The feasibility of canine rabies elimination in Africa: dispelling doubts with data. PLoS Negl Trop Dis. 2010, 4 (2): e626-10.1371/journal.pntd.0000626.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Cliquet F, Robardet E, Must K, Laine M, Peik K, Picard-Meyer E, Guiot AL, Niin E: Eliminating rabies in Estonia. PLoS Negl Trop Dis. 2012, 6 (2): e1535-10.1371/journal.pntd.0001535.CrossRefPubMedPubMedCentral Cliquet F, Robardet E, Must K, Laine M, Peik K, Picard-Meyer E, Guiot AL, Niin E: Eliminating rabies in Estonia. PLoS Negl Trop Dis. 2012, 6 (2): e1535-10.1371/journal.pntd.0001535.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Bingham J, Javangwe S, Sabeta CT, Wandeler AI, Nel LH: Report of isolations of unusual lyssaviruses (rabies and Mokola virus) identified retrospectively from Zimbabwe. J S Afr Vet Assoc. 2001, 72 (2): 92-94.CrossRefPubMed Bingham J, Javangwe S, Sabeta CT, Wandeler AI, Nel LH: Report of isolations of unusual lyssaviruses (rabies and Mokola virus) identified retrospectively from Zimbabwe. J S Afr Vet Assoc. 2001, 72 (2): 92-94.CrossRefPubMed
29.
Zurück zum Zitat Briggs D, Hanlon CA: World Rabies Day: focusing attention on a neglected disease. Vet Rec. 2007, 161 (9): 288-289. 10.1136/vr.161.9.288.CrossRefPubMed Briggs D, Hanlon CA: World Rabies Day: focusing attention on a neglected disease. Vet Rec. 2007, 161 (9): 288-289. 10.1136/vr.161.9.288.CrossRefPubMed
Metadaten
Titel
Epidemiological and clinical features of human rabies cases in Bali 2008-2010
verfasst von
Ni M Susilawathi
Agus E Darwinata
Ida BNP Dwija
Nyoman S Budayanti
Gusti AK Wirasandhi
Ketut Subrata
Ni K Susilarini
Raka AA Sudewi
Frank S Wignall
Gusti NK Mahardika
Publikationsdatum
01.12.2012
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2012
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-81

Weitere Artikel der Ausgabe 1/2012

BMC Infectious Diseases 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.